Literature DB >> 6328911

Interaction of forskolin with resolved adenylate cyclase components.

J L Bender, L G Wolf, E J Neer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6328911

Source DB:  PubMed          Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res        ISSN： 0747-7767


× No keyword cloud information.
  7 in total

1.  Alpha 2-adrenoceptor-mediated inhibition of platelet adenylate cyclase activity in heroin addicts in abstinence.

Authors:  J A García-Sevilla; I Ulibarri; L Ugedo; M Gutierrez
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Inhibition by forskolin of insulin-stimulated glucose transport in L6 muscle cells.

Authors:  A Klip; T Ramlal; A G Douen; P J Bilan; K L Skorecki
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

3.  Role of stimulatory GTP-binding protein (Gs) in reduced beta-adrenoceptor coupling in the femoral artery of spontaneously hypertensive rats.

Authors:  M Asano; K Masuzawa; T Matsuda
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

4.  Re-evaluation of the specificity of adenylyl (beta,gamma-methylene)diphosphonate as a substrate for adenylate cyclase.

Authors:  D Mayer; H J Hacker; P Bannasch
Journal:  Histochem J       Date:  1991-02

5.  The stimulatory guanine-nucleotide regulatory unit of adenylate cyclase from bovine cerebral cortex. ADP-ribosylation and purification.

Authors:  E J Neer; L G Wolf; D M Gill
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

6.  Human 5-HT7 receptor-induced inactivation of forskolin-stimulated adenylate cyclase by risperidone, 9-OH-risperidone and other "inactivating antagonists".

Authors:  Nicole Toohey; Michael T Klein; Jessica Knight; Carol Smith; Milt Teitler
Journal:  Mol Pharmacol       Date:  2009-06-09       Impact factor: 4.436

7.  Evidence for reduced beta-adrenoceptor coupling to adenylate cyclase in femoral arteries from spontaneously hypertensive rats.

Authors:  M Asano; K Masuzawa; T Matsuda
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.